Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Total Current Liabilities (2024 - 2025)

Caris Life Sciences (CAI) has 1 years of Total Current Liabilities data on record, last reported at $165.4 million in Q4 2024.

  • For Q4 2024, Total Current Liabilities changed N/A year-over-year to $165.4 million; the TTM value through Dec 2024 reached $165.4 million, changed N/A, while the annual FY2024 figure was $165.4 million, N/A changed from the prior year.
  • Total Current Liabilities reached $165.4 million in Q4 2024 per CAI's latest filing.
  • Across five years, Total Current Liabilities topped out at $165.4 million in Q4 2024 and bottomed at $165.4 million in Q4 2024.